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Abstract
Exposure to fragranced consumer products, such as air fresheners and cleaning supplies, is associated with adverse health effects
such as asthma attacks, breathing difficulties, and migraine headaches. This study investigated the prevalence and types of health
problems associated with exposure to fragranced products among asthmatic Australians. Nationally representative cross-
sectional data were obtained in June 2016 with an online survey of adult Australians (n = 1098), of which 28.5% were medically
diagnosed with asthma or an asthma-like condition. Nationally, 55.6% of asthmatics, and 23.9% of non-asthmatics, report
adverse health effects after exposure to fragranced products. Specifically, 24.0% of asthmatics report an asthma attack.
Moreover, 18.2% of asthmatics lost workdays or a job in the past year due to fragranced products in the workplace. Over
20% of asthmatics are unable to access public places and restrooms that use air fresheners. Exposure to fragranced products is
associated with health problems, some potentially serious, in an estimated 2.2 million asthmatic adult Australians. Asthmatics
were proportionately more affected than non-asthmatics (prevalence odds ratio 3.98; 95% confidence interval 3.01–5.24). Most
asthmatics would prefer workplaces, healthcare facilities, and environments that are fragrance-free, which could help reduce
adverse effects.
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Introduction
Exposure to fragranced consumer products, such as air fresh-
eners, cleaning supplies, laundry detergents, perfumes, house-
hold items, and personal care products, has been associated
with adverse human health effects (Steinemann 2009). Effects
include headaches and migraines (Andress-Rothrock et al.
2010; Silva-Néto et al. 2013), contact dermatitis (Johansen
2003; Rastogi et al. 2007), infant diarrhea and earache
(Farrow et al. 2003), reductions in lung and pulmonary func-
tion (Dales et al. 2013; Shim and Williams 1986), irritation of
the airway mucosa (Elberling et al. 2005), and exacerbation of
asthma symptoms (Kumar et al. 1995; Millqvist and
Löwhagen 1996; Shim and Williams 1986; Weinberg et al.
2017).
In a study parallel to this one, Steinemann (2016) found
that 34.7% of adult Americans reported health problems when
exposed to fragranced products. Specifically, among
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Americans diagnosed with asthma or an asthma-like condition
(26.8%), Steinemann (2017b) found that 64.3% report one or
more types of adverse health effects, including respiratory
problems (43.3%), migraine headaches (28.2%), and asthma
attacks (27.9%), when exposed to fragranced consumer prod-
ucts. Another recent study showed that 3.8% of all work-
related asthma cases reported in California between 1993
and 2012 were associated with fragranced product exposure,
with the majority attributed to perfume or scented body prod-
ucts (Weinberg et al. 2017). Earlier studies found a higher
prevalence of adverse health effects due to air freshener or
deodorizer exposure among asthmatics (37.2%) than in the
general population (20.5%), along with a higher rate of in-
crease among asthmatics (7.5% compared with 3.0% over
3 years, 2002–2003 to 2005–2006) (Caress and Steinemann
2009).
Fragranced consumer products emit numerous volatile or-
ganic compounds (Steinemann 2015), and a single “fra-
grance” in a product is typically a mixture of several dozen
to several hundred chemicals (Bickers et al. 2003). However,
ingredients in fragranced consumer products do not need to be
fully disclosed to the public on either the label or safety data
sheet (Lunny et al. 2017). If any ingredients are disclosed,
they typically represent fewer than 10% of all ingredients
detected in product analyses (e.g., Uhde and Schulz 2015;
Steinemann 2017c; Steinemann et al. 2011). For instance,
Steinemann (2015) foundmore than 156 volatile organic com-
pounds emitted from 37 fragranced consumer products, the
most common being terpenes (e.g., limonene, alpha-pinene,
and beta-pinene). However, of over 550 volatile ingredients
emitted collectively, including hazardous air pollutants (e.g.,
formaldehyde), fewer than 3% were disclosed on the product
labels, safety data sheets, or websites. Further, even the so-
called green, organic, and natural fragranced products emitted
hazardous air pollutants, similar to regular fragranced prod-
ucts (Steinemann 2015).
The primary objective of this study was to determine the
prevalence and types of health and societal effects associated
with exposure to fragranced products in the Australian popu-
lation, with a focus on individuals with medically diagnosed
asthma or an asthma-like condition. Steinemann (2017a) re-
ports results from the general population survey of
Australians, including both asthmatics and non-asthmatics,
finding that 33% of Australians report adverse effects. This
paper extends and enriches those results by investigating the
effects specifically on the sub-population of asthmatics, and
comparing them with non-asthmatics.
Methods
Using an online national population survey, cross-sectional data
were obtained on types of exposures to fragranced consumer
products, associated effects on health, effects on work and qual-
ity of life, awareness of fragranced product ingredients and
labeling, and preferences for fragrance-free environments.
The survey contained 35 questions (outlined in the
Supplementary Material), each on its own page, with multiple
choice and open format response categories. Categories of
fragranced products evaluated in the survey included air fresh-
eners and deodorizers, personal care products, cleaning sup-
plies, laundry products, household products, and fragrances.
Drawing upon a large panel of over 200,000 Australian
participants held by Survey Sampling International (SSI),
the survey was conducted in June 2016 with 1098 adult (ages
18 to 65) Australians, representative of age, gender, and re-
gion (confidence limit = 95%, margin of error = 3%). SSI is a
survey research company and online panel provider.
Participant recruitment followed a randomized process, and
all responses were anonymous. Survey completion time was
approximately 10 min. No personal information was linked to
the survey results, and data were stored on password-protected
computers. Additional details on survey data and methodolo-
gy, including the Checklist for Reporting Results of Internet
E-Surveys (CHERRIES, Eysenbach 2004), are provided in
the Supplementary Material.
Out of 1098 participants, 313 (28.5%) answered “yes” to
being medically diagnosed by a doctor or healthcare profes-
sional as having asthma or an asthma-like condition. For brev-
ity, these participants will hereafter be referred to as “asth-
matics,” and the other 785 respondents (71.5%) will be re-
ferred to as “non-asthmatics.” Demographics of the survey
respondents are shown in Table 1. Results are summarized
below in four main sections: health problems associated with
exposure, effects of exposure on work and quality of life,
awareness of product emissions, and preferences for
fragrance-free environments.
Statistical analyses
Descriptive statistics and cross tabulations, calculated using
GraphPad Prism v6.07 (GraphPad Software Inc.), determined
the prevalence of outcomes by different sub-populations and
demographics. Chi-squared (χ2) analyses with Yates’ correc-
tion, also calculated using GraphPad Prism v6.07, compared
the proportion of asthmatics with the proportion of non-
asthmatics who answered “yes” to survey questions to deter-
mine whether a statistically significant difference exists.
Prevalence odds ratios (PORs) were calculated to measure
the strength of the association between reported health effects
and asthmatics versus non-asthmatics to determine whether
asthmatics are proportionally more affected than non-asth-
matics. All χ2 and prevalence odds ratio analyses were con-
ducted using a 95% confidence level or confidence intervals.
Further details on methodology and survey data are provided
in the Supplementary Material.
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Results
Key findings of this study are that exposure to fragranced
products is ubiquitous in Australian society, that it is associat-
ed with a range of adverse health effects in 33% of the general
population, and that these adverse health outcomes affect asth-
matics (55.6%)more than non-asthmatics (23.9%) (POR 3.98;
95% CI 3.01–5.24). Further, in each category of adverse
health effect investigated in this study, asthmatics are propor-
tionately more affected than non-asthmatics (Table 2).
Health problems associated with exposure
Virtually all respondents are exposed to fragranced products at
least once a week through their own use (99% for asthmatics,
97.6% for non-asthmatics), others’ use (92.3% for asthmatics,
86.4% for non-asthmatics), or both (99.7% for asthmatics,
98.1% for non-asthmatics).
More than half (55.6%) of asthmatics reported health prob-
lems from exposure to one or more types of fragranced prod-
ucts, compared with approximately one quarter (23.9%) of
non-asthmatics (χ2 = (1, N = 1098) = 97.13, p < 0.001)
(Table 2 and Supplementary Material). Significantly, 24.0%
of asthmatics reported that exposure to a fragranced product
was associated with an asthma attack.
Both asthmatics and non-asthmatics reported health prob-
lemswhen exposed to air fresheners or deodorizers (33.9% for
asthmatics and 9.4% for non-asthmatics), scented laundry
products coming from a dryer vent (12.1% and 3.7%, respec-
tively), being in a room after it has been cleaned with scented
products (30.7% and 9.2%, respectively), and being near
someone who is wearing a fragranced product (36.1% and
12.7%, respectively), with asthmatics proportionately more
affected than non-asthmatics (POR 3.98; 95% CI 3.01–5.24)
(see Table 3).
Moreover, asthmatic Australians were more likely to re-
port health problems for each of the 11 categories of ad-
verse health effects investigated in the survey (χ2 = (1, N =
1098) > 14.82, p < 0.001 in all cases) (see Table 2).
Respiratory problems (e.g., difficulty breathing, coughing,
or shortness of breath) and mucosal symptoms (e.g., watery
or red eyes, nasal congestion, or sneezing) were the most
frequently reported health problems for both asthmatics
(33.9% and 26.5%, respectively) and non-asthmatics
(9.8% and 9.0%, respectively).
Effects of exposure on work and quality of life
Fragranced products can also restrict access in society and
impose costs due to their potential to adversely affect health.
The survey found 21.4% of asthmatics and 7.6% of non-
Table 1 Study participant
demographics Asthmatic
(n, %)
Non-asthmatic
(n, %)
Total 313, 100.0% 785, 100.0%
All Males 143, 45.7% 400, 51.0%
All Females 170, 54.3% 385, 49.0%
Male 18–24 16, 5.1% 54, 6.9%
Male 25–34 34, 10.9% 75, 9.6%
Male 35–44 33, 10.5% 86, 11.0%
Male 45–54 34, 10.9% 92, 11.7%
Male 55–65 26, 8.3% 93, 11.8%
Female 18–24 26, 8.3% 60, 7.6%
Female 25–34 35, 11.2% 95, 12.1%
Female 35–44 42, 13.4% 95, 12.1%
Female 45–54 41, 13.1% 74, 9.4%
Female 55–65 26, 8.3% 61, 7.8%
Australian Capital Territory 6, 1.9% 14, 1.8%
New South Wales 98, 31.3% 262, 33.4%
Northern Territory 2, 0.6% 5, 0.6%
Queensland 66, 21.1% 151, 19.2%
South Australia 25, 8.0% 60, 7.6%
Tasmania 7, 2.2% 18, 2.3%
Victoria 77, 24.6% 201, 25.6%
Western Australia 32, 10.2% 74, 9.4%
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asthmatics are unable or reluctant to use the restrooms in a
public place, because of the presence of an air freshener, de-
odorizer, or scented product (χ2 = (1, N = 1098) = 40.1,
p < 0.0001). In addition, 20.8% of asthmatics and 6.1% of
non-asthmatics are unable or reluctant to wash their hands
with soap in a public place if the soap is fragranced
(χ2 = (1, N = 1098) = 50.46, p < 0.0001). Further, 31.9% of
asthmatics and 8.3% of non-asthmatics had been prevented
from going to some place, because they would be exposed
to a fragranced product that would make them sick
(χ2 = (1, N = 1098) = 96.33, p < 0.0001). Upon entering a
business where they could smell air fresheners or a fragranced
product, 31.0% of asthmatics and 11.0% of non-asthmatics
wanted to leave as quickly as possible (χ2 = (1, N = 1014) =
63.24, p < 0.0001). In the workplace, 18.2% of asthmatics and
3.6% of non-asthmatics have lost workdays or a job, in the
past 12 months, due to exposure to fragranced products in
their work environment (χ2 = (1, N = 1098) = 65.16,
p < 0.001). Thus, in each of these exposure situations, asth-
matics were significantly more likely to report adverse effects
than non-asthmatics.
Awareness of product emissions
Overall, the majority of asthmatics and non-asthmatics were
unaware of potentially hazardous chemicals emitted from
fragranced products, even ones called green or organic, and
would not continue to use a fragranced product if they knew it
emitted these pollutants. Nearly half of asthmatics (42.2%)
and non-asthmatics (49.2%) were not aware that a “fragrance”
in a product is a mixture of several dozen to several hundred
chemicals (χ2 = (1, N = 1098) = 4.123, p = 0.042). Most asth-
matics (67.1%) and non-asthmatics (69.2%) were not aware
that fragrance chemicals do not need to be fully disclosed on
the product label or material safety data sheet (χ2 = (1, N =
1098) = 0.3577, p = 0.550). Similarly, most asthmatics
(70.3%) and non-asthmatics (75.0%) did not know that
fragranced products, even those called natural, green or organ-
ic, typically emit hazardous air pollutants (χ2 = (1, N =
1098) = 2.358, p = 0.125). Importantly, more than half of asth-
matics (60.1%) and of non-asthmatics (54.8%) would not con-
tinue to use a fragranced product if they knew it emitted haz-
ardous air pollutants (χ2 = (1, N = 1098) = 2.332, p = 0.127).
Thus, asthmatics and non-asthmatics were similarly unaware
of fragranced product emissions of hazardous air pollutants
and would similarly cease use of a fragranced product if they
were aware of such emissions.
Preferences for fragrance-free environments
Fragrance-free environments received widespread support
from both asthmatics and non-asthmatics (Table 4). More than
half of asthmatics (50.5%) and nearly half of non-asthmatics
(39.7%) would support a fragrance-free policy in the work-
place, representing almost twice as many that would not sup-
port a policy (χ2 = (1, N = 714) = 6.921, p = 0.008). Nearly
half of both asthmatics (50.2%) and non-asthmatics (40.4%)
would prefer that healthcare facilities and healthcare profes-
sionals were fragrance-free (χ2 = (1, N = 751) = 1.779, p =
0.182). A majority of asthmatics (62.6%) and non-
asthmatics (55.8%) would prefer an airplane without scented
air pumped through the passenger cabin, representing over
three times as many that would prefer unscented air to scented
air (χ2 = (1, N = 813) = 0.082, p = 0.773). A majority of asth-
matics (60.1%) and non-asthmatics (53.8%) would prefer a
hotel without scented air, representing over twice as many that
would prefer unscented air to scented air (χ2 = (1, N = 714) =
0.124, p = 0.724).
Table 2 Prevalence and types of
health problems reported by
individuals who experienced
adverse health effects associated
with exposure to fragranced
products
Asthmatic Non-asthmatic POR (95% CI)
Prevalence (n) Percent Prevalence (n) Percent
Respiratory problems 106 33.9 77 9.8 4.71 (3.38–6.56)
Mucosal symptoms 83 26.5 71 9.0 3.63 (2.56–5.15)
Skin problems 52 16.6 52 6.6 2.81 (1.86–4.23)
Migraine headaches 53 16.9 57 7.3 2.60 (1.74–3.88)
Asthma attacks 75 24.0 8 1.0 30.61 (14.55–64.36)
Neurological problems 28 8.9 21 2.7 3.57 (1.98–6.40)
Cognitive problems 27 8.6 18 2.3 4.02 (2.18–7.42)
Gastrointestinal problems 21 6.7 15 1.9 3.69 (1.88–7.26)
Cardiovascular problems 21 6.7 12 1.5 4.63 (2.25–9.54)
Immune system problems 24 7.7 12 1.5 5.35 (2.64–10.84)
Musculoskeletal problems 18 5.8 11 1.4 4.29 (2.00–9.20)
Other 5 1.6 16 2.0 0.78 (0.28–2.15)
Total 174 55.6 188 23.9 3.98 (3.01–5.24)
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Discussion
Results revealed that nearly all asthmatics used a fragranced
product (99.0%) or were involuntarily exposed to others’ use
of fragranced products (92.3%), or both (99.7%), at least once
a week. Thus, the potential for exposure is widespread, espe-
cially from involuntary exposure. These results are similar to a
nationally representative US population study (Steinemann
2016) showing widespread exposure to fragranced products
from own use (98.3%), others’ use (92.1%), or both (99.1%)
(χ2 = (1, N = 618) = 0.003, p = 0.955).
An individual’s ability to avoid exposure to fragranced
products can also depend on their awareness of product emis-
sions. As prior work has demonstrated (Steinemann 2015;
Lunny et al. 2017), ingredients in fragranced products are not
fully disclosed, making it nearly impossible for the public to
make informed decisions. This problem is exacerbated because
even if products did list all their ingredients, we lack informa-
tion on which chemicals, mixtures, or reaction products could
be associated with the reported adverse effects. In this study, a
majority of asthmatics and non-asthmatics were unaware of the
potentially hazardous ingredients in fragranced products, and
would not use a fragranced product if they knew it emitted
hazardous air pollutants. This indicates that many Australians
may be using fragranced products without their awareness of
exposures. However, products without a fragrance are widely
available, and offer a practical option to reduce risks for people
adversely affected by fragranced products.
Our results indicate that over half of asthmatics (55.6%),
and almost one quarter of non-asthmatics (23.9%), reported
one or more types of adverse health effects associated with
exposure to one or more types of fragranced products.
Asthmatics were more likely to experience adverse health ef-
fects from fragranced products (POR 3.98; 95%CI 3.01–5.24),
regardless of the type of adverse effect (Table 2). Commonly,
asthmatics experienced respiratory problems (POR 4.71; 95%
CI 3.38–6.56) and mucosal symptoms (POR 3.63; 95% CI
2.56–5.15) after exposure to a fragranced product. Similarly,
among Americans, asthmatics were more likely to experience
adverse health effects from fragranced products than non-
asthmatics (POR 5.76; 95% CI 4.34–7.64) (Steinemann
2017a). Also, in two nationally representative studies in the
USA, Caress and Steinemann (2009) found 29.7 and 37.2%
of asthmatics (in 2002–2003 and 2005–2006, respectively)
Table 3 Percentage of
individuals who experienced
adverse health effects associated
with four types of exposure to
fragranced products. AF = air
fresheners or deodorizers, LP =
scent of laundry products coming
from a dryer vent, CP = being in a
room after it has been cleaned
with scented products, FP = being
near someone wearing a
fragranced product
Asthmatic Non-asthmatic
AF LP CP FP AF LP CP FP
Respiratory problems 20.8 5.1 16.6 18.2 4.5 1.5 3.8 4.3
Mucosal symptoms 13.7 4.2 13.1 15.7 3.2 0.5 3.2 4.8
Skin problems 9.3 4.8 5.1 4.2 3.1 1.0 1.9 0.8
Migraine headaches 9.9 2.2 7.0 7.3 1.9 0.9 2.0 3.9
Asthma attacks 14.1 4.5 8.3 10.5 0.6 0.1 0.1 0.5
Neurological problems 5.8 2.6 4.2 4.8 0.8 0.0 0.5 1.4
Cognitive problems 4.5 2.6 4.2 3.5 0.9 0.4 0.9 0.8
Gastrointestinal problems 3.8 3.2 4.2 2.2 0.5 0.4 0.4 1.1
Cardiovascular problems 4.2 4.2 3.8 2.9 1.0 0.3 0.3 0.5
Immune system problems 4.2 5.1 4.2 3.8 0.9 0.5 0.6 0.3
Musculoskeletal problems 3.5 2.9 2.6 3.5 0.9 0.1 0.4 0.3
Other 0.0 0.0 0.6 0.6 0.8 0.3 0.6 0.9
Total 33.9 12.1 30.7 36.1 9.4 3.7 9.2 12.7
Table 4 Percentage of individuals who prefer fragrance-free environments
Asthmatic Non-asthmatic
Yes No Neutral/not sure Decline
to answer
Yes No Neutral/not sure Decline
to answer
Fragrance-free workplaces 50.5% 18.5% 31.0% 0.0% 39.7% 23.7% 36.2% 0.4%
Fragrance-free healthcare facilities
and healthcare professionals
50.2% 24.9% 24.6% 0.3% 40.4% 25.4% 33.8% 0.5%
Airplanes without scented air 62.6% 18.5% 18.8% 0.0% 55.8% 15.4% 28.5% 0.3%
Hotels without scented air 60.1% 23.3% 16.6% 0.0% 53.8% 22.4% 23.6% 0.3%
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reported health problems from air fresheners and deodorizers,
compared with 33.9% of asthmatics in our study.
In addition to direct impacts on health, fragranced products
can also restrict an individual’s access in society, affect their
lifestyle, and have economic and workplace implications. Our
findings indicate that 18.2% of asthmatics face economic im-
plications through loss of workdays or a job, in the past year,
due to fragranced product exposure in the workplace. Over
twice as many asthmatics and non-asthmatics would support
a fragrance-free policy in the workplace (50.5 and 39.7%,
respectively), compared with those that would not (18.5 and
23.7%, respectively).
Study strengths and limitations Our survey population is rep-
resentative of the Australian population (1098 respondents, 95%
confidence level with a 3% margin of error). The 1098 respon-
dents were randomly recruited from a large Web-based panel
(over 200,000 potential participants). The proportion of respon-
dents who stated they had doctor or healthcare professional di-
agnosed asthma (16.0%) is similar to the proportion (19.0%)
reported in the 2007–2008 National Health Survey (AIHW
2011). Our survey questions were based on a study previously
conducted and published (Steinemann 2017b). Study limitations
include its cross-sectional design, being restricted to adults (18–
65 years), and reliance on self-reported data. The cross-sectional
design means that we are unable to infer temporal associations
between exposures and outcomes. Restricting respondents to
adults between 18 and 65 years of age excludes data on effects
of fragranced products on children and the elderly. Self-reports
are commonly used in survey-based research; however, respon-
dent data were not externally verified. Our lists of potential
health effects were not exhaustive; however, only 1.6% of asth-
matics and 2.0% of non-asthmatics reported health effects “oth-
er” than those included in our lists, suggesting that primary
effects were likely captured. Finally, we lack data on the severity
or frequency of adverse health outcomes, such as whether ex-
posure to a single fragranced product was associated with a
single or multiple health outcomes.
In our survey, 28.5%of respondents answered “yes” to having
either doctor or healthcare professional diagnosed asthma
(16.0%), or an asthma-like condition (13.8%), or both. Thus,
the 55.6% of “asthmatics” in our studywho report adverse health
effects due to fragranced product exposure would represent over
2.2 million adult Australians (ABS 2016). Combining this with
the 23.9% of “non-asthmatics” (71.5%) who also report adverse
health effects would represent over 4.5 million adult Australians
affected adversely by fragranced consumer products.
Conclusions
Results from this study show that voluntary and involuntary
exposure to fragranced products is widespread in Australian
society, that exposure is associated with a range of potentially
serious and adverse health effects, and that these effects are
more common in people with asthma or an asthma-like con-
dition. In addition to the adverse health consequences, expo-
sure to fragranced products imposes significant adverse im-
pacts on workplace productivity and quality of life, including
the ability to access public places such as restrooms. A
straightforward approach to reduce undesirable effects would
be to reduce or avoid use of fragranced products, especially in
public places that would impose involuntary risks, and to im-
plement fragrance-free policies in workplaces, healthcare fa-
cilities, and other environments.
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